Full-Time
Global producer of specialized aqueous polymers
No salary listed
Company Does Not Provide H1B Sponsorship
Rock Hill, SC, USA
In Person
On-site role in Chester, South Carolina; USC
Bachelor's
See people who can refer or advise you
Synthomer develops and supplies aqueous polymer dispersions and specialised polymers for coatings, construction, adhesives, textiles, paper and health-related products. These polymers are designed and manufactured to deliver adhesion, durability and compatibility with different substrates, and are tailored to each customer’s processes and performance requirements. The company differentiates itself through a global footprint and a focus on high-performance, customised solutions rather than off-the-shelf products, with close collaboration with customers. Its goal is to help customers achieve their performance targets by providing reliable, high-quality polymers and expanding its global reach in key markets.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
London, United Kingdom
Founded
1908
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Synthomer lifts FY outlook after strong first half. 92.70p. 15:21 04/08/26. Chemicals company Synthomer lifted its full-year outlook on Tuesday following a strong first half. 7,949.14. 5,863.20. 8,127.96. 15:22 04/08/26. In the six months to 30 June, underlying operating profit rose 41.7% to £48.6m, with revenue up 6.7% at £954.3m and all divisions contributing growth. Revenue in Coatings & Construction Solutions (CCS) was up 33.3% at £46m, while revenue from Adhesive Solutions (AS) edged up 3.7% to £36.7m. The Health & Protection and Performance Materials business (HPPM) saw revenues rise 13.7% to £24.9m. Earnings before interest, tax, depreciation and amortisation increased 16.4% to £96.7m. Synthomer said it now expects its FY26 performance to be "slightly ahead" of market expectations for EBITDA of £162m. This reflects a strong first half, led by strategic growth and self-help, supporting further progress in the second half despite ongoing geopolitical uncertainties, it said. Chief executive Michael Willome said: "Synthomer has delivered a strong performance so far in 2026, with the majority of the progress Sharecast has made coming from its sustained efforts to become a more speciality-focused company and its consistent work to 'control the controllables'. This includes its focus on growing its higher margin products and accessing new markets, customer-led innovation, optimising its regional manufacturing strategy and further cost and complexity reductions. "While our agility and ability to deliver helped our customers navigate the challenging operating conditions in Q2, the market environment will continue to require us to be fast and bold. We are confident that by remaining true to our speciality strategy, we will continue to strengthen our balance sheet and deliver further sustainable earnings growth." At 1130 BST, the shares were up 5.4% at 93.78p. Broker Peel Hunt, which rates the shares at 'buy' with a 200p price target, said H1 EBITDA was ahead of its estimate of £88m. It increased its 2026 EBITDA forecast from £160m to £165m. "The route to the medium-term targets, coupled with debt normalisation, is looking increasingly well established," it said. "We view 200p as a realistic next-step target."
Synthomer raises its outlook after cost cuts pay off. The UK specialty chemicals firm lifted its full-year profit and cash flow view after first-half core profit rose 13.4% to £96.7 million. about 1 hour ago - 2 mins What's going on here? Synthomer, a UK specialty chemicals firm, raised its full-year profit and cash flow outlook after first-half core profit rose 13.4% to £96.7 million, sparking a sharp rally in its shares. What does this mean? Synthomer makes polymers used in coatings, adhesives, and medical gloves, and it says its turnaround is starting to show in the numbers. Cost cuts and a tilt toward higher-margin specialty products helped lift first-half core profit to £96.7 million as revenue rose nearly 7% to £954.3 million, according to Reuters. The company now expects 2026 core profit to come in slightly ahead of market expectations and says it's on track for positive free cash flow... Keep reading for free. This content is free, but you must be logged in to continue reading. Already have an account?
Jeff Chaapel joins LGG Industrial as Vice President & General Manager, U.S. West Region. Published by LGG Industrial. Pittsburgh, PA - LGG Industrial is pleased to announce the appointment of Jeff Chaapel as Vice President & General Manager, U.S. West Region. Chaapel brings nearly 30 years of progressive leadership experience. Most recently, Chaapel served as Vice President of Energy Solutions at Synthomer, where he spent the past 13 years building and scaling an incubated business into a global market leader. "Jeff's depth of industry knowledge and leadership experience make him an excellent fit for LGG Industrial," said Jeff Crane, Chief Executive Officer of LGG Industrial. "We are very excited to welcome him to the LGG Industrial team." In this role, Jeff will provide strategic leadership for the West Region's sales strategy and growth opportunities. Lewis-Goetz & Co Inc is excited to welcome Jeff Chaapel to LGG Industrial and look forward to the leadership and experience he will bring to its organization. About LGG Industrial LGG Industrial is the go-to partner for industrial companies looking for fluid handling, sealing, and material conveyance solutions. Headquartered in Pittsburgh, Pennsylvania and supported by Luther King Capital Management, LGG Industrial has decades of experience creating value for the North American industrial market with a passion for customer service that is met with deep technical know-how.
Mutares shares fall 10% YTD despite €2 dividend; technicals bearish. Firm races to close Synthomer
Synthomer divests acrylate monomers business to Mutares. Synthomer has announced the divestment of its acrylate monomers business, marking a strategic move to simplify its portfolio and focus on speciality chemicals. The Czech-based business will transition to Mutares, a private equity firm specialising in company turnarounds. 19 June 2026 Synthomer, a leading global supplier of high-performance polymers, has confirmed the divestment of its acrylate monomers business in the Czech Republic. The business, which operates under Synthomer a.s., will be acquired by Mutares, a Munich-based private equity company with expertise in transforming industrial businesses. This decision is part of Synthomer's strategic shift towards a streamlined portfolio centred on speciality chemicals with higher margins and growth potential. Acrylate Monomers, a key supplier of acrylic acid and related monomers to the European market, employs approximately 300 staff at its Sokolov manufacturing site. The site also contributes to Synthomer's downstream operations by supplying acrylic monomers to Group companies and producing acrylic dispersions. Under the new ownership, these supply arrangements will remain intact. Strategic portfolio simplification The divestment reflects Synthomer's strategy to exit highly cyclical and capital-intensive sectors. Acrylate Monomers was the last remaining upstream business in Synthomer's portfolio and had been designated as non-core following a strategic review in October 2022. Michael Willome, CEO of Synthomer, stated, "This announcement is another important step in delivering our strategy to simplify our business and sharpen our focus on higher-margin, higher-growth speciality chemicals markets where we have strong and sustainable leadership positions." He expressed confidence in Mutares' ability to steer Acrylate Monomers through its next phase of development. Financial dynamics and transaction details In 2025, Acrylate Monomers reported external sales of EUR 68 million but faced an adjusted EBITDA loss of EUR 10 million. Improved trading conditions in early 2026, influenced by short-term market fluctuations and cost reductions, led the business to a break-even point. Synthomer noted that Acrylate Monomers requires approximately EUR 5 million annually in capital expenditure, highlighting its capital-intensive nature. The transaction, expected to close at the end of Q3 2026, includes a cash generation sharing arrangement of up to EUR 12 million over three years, with no initial payment at closing. To ensure operational continuity, the divested company will receive EUR 5 million in cash for working capital requirements.